Dapagliflozin

AstraZeneca’s Dapagliflozin Gets Approval for Chronic Kidney Disease in India

KOCHI:AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, today announced that they have received marketing authorisation for…

3 years ago

AstraZeneca’s Forxiga Approved in India for Treatment of Patients with Heart Failure

BENGALURU: AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, today received the government approval for Dapagliflozin (Forxiga),…

4 years ago

AstraZeneca’s Diabetes Drug Shows Significant Benefits in Patients with Heart Failure

MUMBAI: Studies indicate that every 8 th Heart Failure patient in the world is an Indian of which 40% also…

5 years ago

Glenmark Pharmaceuticals Announces Launch of Latest-in-class Diabetes Medicine

  KOCHI: Glenmark Pharmaceuticals Ltd (Glenmark), a research-led global integrated pharmaceutical company, today announced the launch of its novel, patent protected and…

5 years ago

Tag Cloud

Cochin University Coronavirus COVID-19 Covid-19 Pandemic Cusat death toll FC Goa health ministry Hero Indian Super League Kerala Startup Mission Kerala Tourism Kochi - Muziris Biennale Kochi Biennale Foundation KSUM lockdown Narendra Modi Pinarayi Vijayan Social Media Supreme Court Tata Motors

This website uses cookies.